Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization

Eiji Sakurai1, Hogara Taguchi, Akshay Anand

  • 1Department of Ophthalmology, University of Kentucky, Lexington, Kentucky 40536-0284, USA.

Abstract

Insights

Leukocyte adhesion molecules CD18 and ICAM-1 play a key role in choroidal neovascularization (CNV). Mice lacking CD18 or ICAM-1 showed significantly reduced CNV development and leakage, indicating their importance.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vascular Biology

Background:

  • Choroidal neovascularization (CNV) is a major cause of vision loss.
  • Leukocyte adhesion molecules are crucial for immune cell trafficking and inflammation.
  • The specific roles of CD18 and ICAM-1 in CNV pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the involvement of leukocyte adhesion molecules CD18 and intercellular adhesion molecule (ICAM)-1 in the development of laser-induced choroidal neovascularization (CNV).

Main Methods:

  • Laser photocoagulation was used to induce CNV in wild-type, CD18-deficient, and ICAM-1-deficient mice.
  • Expression of CD18 and ICAM-1 was assessed by immunostaining post-injury.
  • CNV volume and fluorescein leakage were quantified using confocal microscopy and angiography.

Main Results:

  • Upregulation of ICAM-1 and CD18-positive leukocyte infiltration occurred rapidly after laser injury.
  • CD18- and ICAM-1-deficient mice exhibited significantly reduced CNV leakage and lesion volume compared to wild-type controls.
  • Fewer lesions showed significant fluorescein leakage in CD18- and ICAM-1-deficient mice.

Conclusions:

  • Leukocyte adhesion to vascular endothelium, mediated by CD18 and ICAM-1, plays a critical and nonredundant role in the development of laser-induced CNV.
  • Targeting these adhesion molecules may offer a therapeutic strategy for CNV.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...